5112.SH.JN - High Yield Electrospinning System

le to patients and has been evaluated for clinical use in human studies. The team at Sheffield are world leading. We have reported that such matrices can incorporate and release a range of lipophilic, low molecular mass compounds that rapidly diffuse throughout the mucosa following release and witho

ut loss of properties. Moreover, we have incorporated larger macromolecules such as peptides and proteins and achieved high loading efficiency, rapid release profiles and retention of functional activity. The patches are prepared using ele